Immune System Genes Linked to Chronic Lymphocytic Leukemia
By LabMedica International staff writers Posted on 24 Feb 2017 |

Image: Chronic lymphocytic leukemia. The peripheral blood smear shows an absolute lymphocytosis of small “mature” lymphocytes with clumped, smudgy chromatin and scant cytoplasm. Smudge cells (near the top right) are a common finding (Photo courtesy of Cleveland Clinic).
Chronic lymphocytic leukemia (CLL) is an indolent B-cell malignancy that has a strong genetic component, as evidenced by the eightfold increased risk seen in relatives of CLL patients.
The risk of developing chronic lymphocytic leukemia (CLL) has been linked to the inheritance of nine regions of DNA, five of which help white blood cells fight disease.
An international team, co-led by scientists at The Institute of Cancer Research perform a meta-analysis of six genome-wide association studies, imputed using a merged reference panel of 1,000 Genomes and UK10K data, totaling 6,200 cases and 17,598 controls after replication. They analyzed genome-wide association data from populations of European ancestry from Europe, North America and Australia, identifying nine new risk loci.
The fidelity of imputation as assessed by the concordance between imputed and directly genotyped single nucleotide polymorphisms (SNPs) was examined in a subset of samples. Replication genotyping of UK samples was performed using competitive allele-specific polymerase chain reaction (PCR KASPar) chemistry. Replication genotyping of Mayo samples was performed using Sequenom MassARRAY.
The team found that one of the new variants resides in the gene B-cell scaffold protein with ankyrin repeats 1 (BANK1), only ever activated in a type of white blood cell called B cells, and linked to the autoimmune disease lupus. Another was found in the gene Zinc finger and BTB domain-containing protein 7A (ZBTB7A), which regulates B cells numbers, so errors in this gene could lead to too many B cells in the bloodstream and bone marrow. A third was found in a region of chromosome 22, which has been linked with the risk of developing multiple sclerosis.
Richard Houlston, MD, PhD, a Professor of Molecular and Population Genetics and co-leader of the study, said, “We knew people were more likely to develop chronic lymphocytic leukemia if someone in their family had suffered from the disease, but our new study takes a big step towards explaining the underlying genetics. CLL is essentially a disease of the immune system, and it's fascinating that so many of the new genetic variants we have uncovered seem to directly affect the behavior of white blood cells and their ability to fight disease.” The study was published on February 6, 2017, in the journal Nature Communications.
The risk of developing chronic lymphocytic leukemia (CLL) has been linked to the inheritance of nine regions of DNA, five of which help white blood cells fight disease.
An international team, co-led by scientists at The Institute of Cancer Research perform a meta-analysis of six genome-wide association studies, imputed using a merged reference panel of 1,000 Genomes and UK10K data, totaling 6,200 cases and 17,598 controls after replication. They analyzed genome-wide association data from populations of European ancestry from Europe, North America and Australia, identifying nine new risk loci.
The fidelity of imputation as assessed by the concordance between imputed and directly genotyped single nucleotide polymorphisms (SNPs) was examined in a subset of samples. Replication genotyping of UK samples was performed using competitive allele-specific polymerase chain reaction (PCR KASPar) chemistry. Replication genotyping of Mayo samples was performed using Sequenom MassARRAY.
The team found that one of the new variants resides in the gene B-cell scaffold protein with ankyrin repeats 1 (BANK1), only ever activated in a type of white blood cell called B cells, and linked to the autoimmune disease lupus. Another was found in the gene Zinc finger and BTB domain-containing protein 7A (ZBTB7A), which regulates B cells numbers, so errors in this gene could lead to too many B cells in the bloodstream and bone marrow. A third was found in a region of chromosome 22, which has been linked with the risk of developing multiple sclerosis.
Richard Houlston, MD, PhD, a Professor of Molecular and Population Genetics and co-leader of the study, said, “We knew people were more likely to develop chronic lymphocytic leukemia if someone in their family had suffered from the disease, but our new study takes a big step towards explaining the underlying genetics. CLL is essentially a disease of the immune system, and it's fascinating that so many of the new genetic variants we have uncovered seem to directly affect the behavior of white blood cells and their ability to fight disease.” The study was published on February 6, 2017, in the journal Nature Communications.
Latest Molecular Diagnostics News
- Genetic-Based Tool Predicts Survival Outcomes of Pancreatic Cancer Patients
- Urine Test Diagnoses Early-Stage Prostate Cancer
- New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
- Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
- Revolutionary Blood Test Detects 30 Different Types of Cancers with 98% Accuracy
- Simple Blood Test Better Predicts Heart Disease Risk
- New Blood Test Detects 12 Common Cancers Before Symptoms Appear
- Blood Test Could Predict Relapse of Autoimmune Blood Vessel Disease
- First-of-its-Kind Blood Test Detects Trauma-Related Diseases
- Key Gene Identified in Common Heart Disease Unlocks Life-Saving Diagnostic Potential
- Cheap Cell-Free DNA Based Test Accurately Predicts Preterm Birth
- RNA Blood Test Detects Cancers and Resistance to Treatment
- IL-6 Outperforms Traditional Tests for Early Sepsis Detection
- Simple Blood Test Improves Heart Attack and Stroke Risk Prediction
- Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
- Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Channels
Clinical Chemistry
view channel
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read more
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
AI-Based Model Predicts Kidney Cancer Therapy Response
Each year, nearly 435,000 individuals are diagnosed with clear cell renal cell carcinoma (ccRCC), making it the most prevalent subtype of kidney cancer. When the disease spreads, anti-angiogenic therapies... Read more
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read moreTechnology
view channel
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more